Definiens Details

Definiens

Company Profile:
Definiens is the number one Enterprise Image Intelligence^TM company, supporting customers in analysing and interpreting images on every scale, from microscopic cell structures to satellite images. Pharmaceutical and biotech companies use Definiens technology to reduce risk, late stage attrition and time to market. Definiens technology enables scientists to analyse and correlate image information all along the drug development chain, supporting translational medicine. At all powers of magnification, our technology enables customers to accomplish every task of image analysis, delivering deeper insights, faster results and better decisions.

Previous Clients:
Pfizer, Cenix BioScience, AstraZeneca, GlaxoSmithKline, Novartis, MIT Whitehead Institute, Max Planck Institute, Merck & Co, Exelixis, Sanofi-Aventis, Harvard Medical School and Genentech, etc.

Key Products:
Since 1994, Nobel Laureate Gerd Binnig and a team of image analysis experts have been perfecting a revolutionary approach to image analysis. Highly regarded for its ability to emulate human cognitive processes, Definiens Cognition Network Technology® helps life science organisations to combine their expert knowledge with scalable computing capacity to vastly accelerate and improve the extraction of intelligence from images. The reliable and standardised quantification of biological structures from vast amounts of image data provides a critical advantage for the early identification of failed drug candidates and more reliable demonstrations of success in drug development.

Website:
www.definiens.com